Ann: Sky addresses media speculation, page-3

First 3 Last

Share
Profile

Follow
Klogg

3,609 Posts.

484

07/06/22

13:16

Post #: 61866413
Share

Originally posted by MarsC: ↑

Here's an interesting perspective by Duncan Greive. I'm not necessarily convinced, but I do find Duncan to be a thoughtful & highly knowledgeable observer of the NZ media scene.

https://thespinoff.co.nz/media/07-06-2022/sky-is-in-advanced-talks-to-buy-mediaworks-what-would-that-mean

In short, he's talking about synergies in terms of becoming one of the largest (traditional) advertising mediums in NZ. Certainly this would have pulling power to NZ advertisers. Of course, the reality is that ad revenue is only a small part of SKT's current revenues & I'd rather see the "synergy" word invoked in terms of attracting eyeballs rather than advertisers. That said, there may be a synergy here too - if say SKT were to offer a lower cost (ad supported) streaming offering (something Netflix themselves are currently contemplating).

So all is not as clear as it seems and I'm willing to hear management out (though I've already fired off a rather forceful letter... ). This is what I was alluding to before: the market is so looking for foibles when it comes to SKT that it is tending to shoot first & ask questions later. Those that sold today may well have jumped the gun (possibly).

@mistaTea
@Klogg

Expand

From that article, the only benefits I can see to having the two companies combinsed are:
- Sky can soak up excess ad inventory
- Maybe a 24 hour news channel

Seems like they're reaching, but let's see what SKT say first.

SKT Price at posting: $2.19 Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 30 more messages in this thread...

First 3 Last

Add SKT (ASX) to my watchlist

(20min delay)
Last $2.40		Change -0.015(0.62%)		Mkt cap ! $330.4M

Open	High	Low	Value	Volume
$2.45	$2.45	$2.40	$26.46K	11K

Buyers (Bids)

No.	Vol.	Price($)
3	4175	$2.40

Sellers (Offers)

Price($)	Vol.	No.
$2.47	1350	1

View Market Depth

No.	Vol.	Price($)
3	4175	2.400
1	8158	2.390
1	1029	2.380
1	92	2.300
1	4500	2.250

Price($)	Vol.	No.
2.470	1350	1
2.500	19730	4
2.600	5374	2
2.650	12500	1
2.710	29234	2

Last trade - 10.24am 04/10/2024 (20 minute delay)

SKT (ASX) Chart

Ann: Sky addresses media speculation, page-3

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Sky addresses media speculation, page-3

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News